Grants and Contributions:
Title:
Accelerating market adoption of iProgen's drug delivery technology
Agreement Number:
942341
Agreement Value:
$32,100.00
Agreement Date:
Jan 10, 2020 - Jun 30, 2020
Description:
Understand the market, key players, potential local partners and develop strategy for market penetration; identify potential clients, collaborators, and partners through trade show and meeting them in person and implement strategy
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Burnaby, British Columbia, CA V5A 4N4
Reference Number:
172-2019-2020-Q4-942341
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
826908816
Recipient Type:
For-profit organization
Recipient's Legal Name:
iProgen Biotech Inc.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541710